CClinicalTrials.gg
CompletedNCT05279794Updated May 20, 2022

Efficacy of Two Types of Non-invasive Erector Spinae Muscle Taut Band Therapy in University Students With Low Back Pain

An interventional study of Jones Group (Strain Counterstrain) and Myofascial Induction Group in Low Back Pain and Trigger Point Pain, Myofascial, sponsored by Universidad Católica San Antonio de Murcia. Completed at 1 site in Spain. Open to participants aged 19 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-20.

Sponsored by Universidad Católica San Antonio de Murcia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
19 Years to 40 Years
Sex
All
01

Study summary

Non-specific low back pain can be caused by the presence of active trigger points in the muscles of the lumbopelvic region. Trigger points are defined as hypersensitive points within a taut band of a musculoskeletal system that cause pain during contraction, stretching, or stimulation of said muscle. If these points are active, they can trigger referred pain, local tenderness, and vegetative responses. There is scientific evidence of the improvement of the treatment of these points through non-invasive manual techniques. The objective of this study will be to determine the effect of Strain Counterstrain and Myofascial Induction techniques in subjects with low back pain secondary to the presence of active trigger points in the lumbopelvic region. Hyperexcitable myofascial trigger points located within a taut band of skeletal muscle or fascia cause referred pain, local tenderness, and autonomic changes. The scientific data refer to an immediate improvement in the symptoms of these active points treated with manual therapy. Based on these factors, the objective of the study is to determine the effect of the combined therapy of the Strain Counterstrain technique and Myofascial Induction in participants with the presence of an active trigger point in the erector spinae muscle.

Read the detailed description

The treatment will last a total of 15 minutes accompanied by a baseline assessment and after 10 minutes of the intervention in 2 experimental groups and a placebo group, of no-pain positioning. In addition to basic indices and scales of low back pain and disability caused by low back pain, it is intended to measure flexibility, range of motion, proprioception and cognition through software with sensors of the latest technology when representing reliable results in differences between techniques.

02

Conditions studied

  • Low Back Pain
  • Trigger Point Pain, Myofascial

Keywords

  • Physiotherapy
  • Rehabilitation
  • Treatment
  • Active Trigger Point
03

In context

Myofascial Pain Syndromes

1,136 studies on the registry are indexed under Myofascial Pain Syndromes; 137 are open to participants now.

This study's enrollment of 60 is close to the median of 60 across 931 interventional studies indexed under Myofascial Pain Syndromes.

Browse Myofascial Pain Syndromes studies →

Lead sponsor

Universidad Católica San Antonio de Murcia is the lead sponsor of 132 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Presence of low back pain
  • Presence of active trigger point in the erector spinae as described by Lawrence H. Jones

Exclusion criteria

Exclusion Criteria:

  • Participants who present dizziness, vertigo;
  • Previous or scheduled surgeries in the lumbar spine and/or lower extremities;
  • Suspicion of serious fractures or pathologies (tumor, inflammation, infection, rheumatological disorder, systemic disease, presence of fever);
  • Diagnosis of radiculopathy or neuropathy;
  • Structural deformity in the spine; spondyloarthropathy, disabling pain and physical disability;
  • Use of pain relievers or anti-inflammatory drugs in the last 48 hours;
  • Neurological or psychiatric disorder;
  • Presence or suspicion of pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Jones Group (Strain Counterstrain)

    Jones Group consist in 90 seconds in a ralease positioning of no pain in muscle acortation

    Other: Jones Group (Strain Counterstrain)

  • Active comparator
    Myofascial Induction Group

    Myofascial Induction Group consist in 15 minutes of superficial and deep lumbar fascia maneuvers

    Other: Myofascial Induction Group

  • Placebo comparator
    Placebo Group

    Placebo Group only have to mantain no pain positioning for 3 minutes

    Other: Placebo Group

Interventions

  • OtherJones Group (Strain Counterstrain)

    No pain positioning technique with diaphragmatic breathing

  • OtherMyofascial Induction Group

    Myofascial Induction technique on the lumbar fascia

  • OtherPlacebo Group

    No pain positioning of participants

06

What researchers measure

Primary outcomes

  1. Pain intensity

    Measured with Numeric Rating Scale wich consist in measure pain intensity with a score of 0-10

    Time frame: 20 minutes

  2. Pression algometer

    Measures pressure pain thresholds

    Time frame: 20 minutes

Secondary outcomes

  1. Spinal test

    Measured with Baiobit Software. The range of movement will be measured in grades as per: flexion/extension; right/left rotation; and right/left inclination

    Time frame: 20 minutes

  2. Countermovement jump test

    Measured with Baiobit software counter movement jump test wich consist a velocity, height and accuracy evaluation of a vertical jump

    Time frame: 20 minutes

07

Study locations

1 site
  • Universidad Católica de Murcia
    Murcia, 30107, Spain
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 20, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05279794
Lead sponsor
Universidad Católica San Antonio de Murcia
Responsible party
Juan Martínez Fuentes (Study Director, Universidad Católica San Antonio de Murcia) — Principal investigator
First posted
Mar 15, 2022
Start date
Mar 21, 2022
Primary completion
Mar 23, 2022
Completion
May 19, 2022
Last update
May 20, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion